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Abstract	
The	 work	 here	 describes	 the	 synthesis	 of	 tailor-made,	 porous,	 polymeric	materials	 with	 elastic	
moduli	 in	 the	 range	associated	with	mammalian	brain	 tissue	 (0.1-24	kPa).	 Three	new	emulsion-
templated	 porous	 polymer	 materials	 (polyHIPEs)	 were	 synthesised	 by	 thiol-ene	
photopolymerisation	 from	 hexanediol	 diacrylate	 (HDDA)	 and	 polyethylene	 glycol	 diacrylate	
(PEGDA)	 crosslinkers	 and	 compared	 with	 a	 previously	 reported	 material	 prepared	 from	
trimethylolpropane	 triacrylate	 (TMPTA).	 The	 materials	 were	 found	 to	 have	 an	 average	 pore	
diameter	of	30-63	μm	and	a	porosity	of	77%	and	above.	PEGDA	crosslinked	materials	at	80	and	85%	
porosity,	when	swollen	in	PBS	at	37°C,	were	found	to	have	an	elastic	modulus	of	18	and	9.0	kPa	
respectively.	PEGDA	crosslinked	materials	were	also	found	to	have	a	swelling	ratio	of	700%	in	PBS	
at	 37°C.	 PEGDA	 crosslinked	 materials	 had	 improved	 visible	 light	 transmission	 properties	 when	
compared	 to	 TMPTA	 crosslinked	 materials	 under	 a	 bright	 field	 microscope.	 All	 materials	 were	
shown	via	hematoxylin	and	eosin	 staining	 to	 support	 the	 infiltration	and	attachment	of	 induced	
pluripotent	stem	cell	(iPSC)-derived	human	neural	progenitor	cells	(hNPCs).	HNPCs	on	all	materials	
were	 demonstrated	 in	 short	 term	 3D	 cultures	 to	 maintain	 a	 phenotype	 consistent	 with	 early	
neural	 lineage	 specification	 via	 immunohistochemical	 staining	 for	 the	 intermediate	 filament	
protein	vimentin.		 	
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Introduction	
The	 human	 brain	 is	 the	 most	 complex	 and	 least	 understood	 organ	 of	 the	 human	 body.	 Key	
challenges	 for	 researchers,	 given	 rapidly	 aging	populations	 in	developed	 countries,	 are	not	only	
understanding	 how	 neurological	 diseases	 develop,	 but	 also	 how	 to	 stop	 their	 progression.	 A	
plethora	of	neurological	disorders	and	diseases	exist,	yet	little	to	no	cures	are	apparent	for	many	
of	 these	 conditions.	 The	 limited	 access	 to	 live	 human	 neural	 tissue,1	 along	with	 physiologically	
inaccurate	 2D	 cell	 cultures2	 and	 questionably	 valid	 mouse	models3,	 4	 have	 made	 it	 difficult	 for	
researchers	 to	 study	 the	 human	brain	 and	 human	neurological	 disorders.	 Advances	 in	 this	 field	
require	new	tools	with	which	to	recreate	human	neural	tissue	in	vitro,	and	produce	representative,	
healthy	 tissue	 and	 disease	models,	 for	 the	 study	 of	 neurological	 diseases	 and	 new	 therapeutic	
targets.	
	
3D	 cell	 culture	 and	 tissue	 engineering	 techniques	 aim	 to	 produce	 cells	 and	 tissue	 that	 are	
physiologically	 comparable	 to	 those	 found	 in	 vivo.	 Cells	 receive	 a	 variety	 of	 cues	 from	 their	
surrounding	environment	 including:	 the	extracellular	matrix	 (ECM),	 soluble	 factors	 and	adjacent	
cells,	which	can	influence	cell	behaviour.	By	designing	tailor-made	tissue	engineering	scaffolds	that	
mimic	as	closely	as	possible	the	native	ECM	of	the	desired	tissue-type,	it	is	possible	to	grow	tissue	
in	vitro	with	greater	physiological	accuracy	than	current	systems,	which	typically	are	flat,	stiff	2D	
substrates.		Biomaterials	used	as	tissue	engineering	scaffolds	come	in	a	range	of	formats,	but	must	
generally	be	highly	porous	 to	allow	cell	 infiltration	and	adequate	nutrient/waste	diffusion,	have	
similar	mechanical	properties	to	the	tissue	of	interest,	be	able	to	degrade	at	a	suitable	rate	to	non-
toxic	degradation	products	and	be	biocompatible.5,	6	
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Somatic	stem	cells	exist	in	specifically	defined	microenvironments	known	as	niches.	These	niches	
deliver	 specific	 extracellular	 cues	 typically	 in	 the	 form	 of	 cell-cell	 interactions,	 cell-factor	
interactions	 and	 cell-matrix	 interactions.	 Through	 these	 interactions	 the	 stem	 cell	 niche	 can	
support	the	self-renewal	of	stems	cells	as	well	as	trigger	the	specific	linage	commitment	of	stem	
cells.7	 The	 neural	 stem	 cell	 niche	 is	 located	 primarily	 in	 the	 sub	 ventricular	 zone	 of	 the	 human	
brain,	and	provides	the	specific	set	of	conditions	for	the	maintenance	of	neural	stem	cells	and	the	
commitment	 of	 neural	 stem	 cells	 to	 neuronal	 and	 glial	 cell	 lineages	 for	 the	 growth	 of	 neural	
tissue.8	The	neural	stem	cell	niche-ECM	is	comprised	of	a	hyaluronic	acid	back	bone9	and	proteins	
laminin,	 fibronectin,	 proteoglycans	 and	 other	 molecules.10	 When	 designing	 advanced	 in	 vitro	
environments	 for	 the	 creation	 of	 stem	 cell-derived	 tissue	 it	 is	 important	 to	 take	 design	
characteristics	from	the	stem	cell	niche	as	much	as	possible.11	
	
Access	 to	 live,	 developing	 human	 neural	 tissue	 is	 extremely	 limited	 due	 to	 the	 sensitivity	 and	
accessibility	 of	 the	 brain,	 therefore	 current	 research	 techniques	 take	 advantage	 of	 human	
pluripotent	stem	cells	(hPSCs)	and	subsequent	directed	differentiation	techniques.	HPSCs	obtained	
from	 human	 embryos,12	 human	 embryonic	 stem	 cells	 (hESCs),	 or	 derived	 from	 somatic	 cells,13	
induced	 pluripotent	 stem	 cells	 (iPSCs),	 have	 the	 ability	 to	 differentiate	 to	 all	 cell	 types	 in	 the	
human	body.	By	specifically	controlling	in	vitro	environments,	hPSC	differentiation	can	be	directed	
toward	 certain	 cell	 lineages	 to	 produce	 a	 variety	 of	 cell	 types.	 Human	 neural	 progenitor	 cells	
(hNPCs)	 can	 be	 quickly	 and	 efficiently	 generated	 from	 hPSCs	 via	 single14-16	 and	 dual	 SMAD	
pathway	 inhibition.17	 Techniques	 like	 these	 make	 it	 possible	 to	 study	 cells	 that	 are	 otherwise	
extremely	difficult	to	gain	access	to	in	vitro.	
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It	 is	 important	 for	tissue	engineering	scaffolds	to	mimic	the	mechanical	properties	of	 the	tissue-
type	of	interest.	The	mechanical	properties	of	mammalian	brain	tissue	have	been	widely	studied	
via	 a	 variety	 of	 methods,	 including:	 mechanical	 testing	 in	 tension	 and	 compression;18	 dynamic	
mechanical	analysis;19	atomic	force	microscopy;20	and	indentation	testing.21	Tissue	from	a	variety	
of	species,	including	human,	primate,	porcine	and	rat	has	been	studied.	The	elastic	modulus	of	the	
mammalian	brain	can	be	broadly	classified	to	be	 in	the	region	0.1-24	kPa22,	23	depending	on	test	
methods,	 test	 conditions	 and	 species,	 as	 well	 as	 on	 age	 and	 development.	 	 When	 designing	
materials	 for	neural	 tissue	engineering	 it	 is	 important	 that	 their	elastic	modulus	 falls	within	 this	
range.	Scaffold	stiffness	has	been	shown	to	affect	the	ability	of	mouse	embryonic	and	rat	neural	
stem	 cells	 to	 attach,	 survive,	 proliferate	 and	 differentiate	 to	 neurons	 and	 glia	 on	 a	 range	 of	
different	substrates.24-27	
	
3D	porous	polymeric	materials	have	shown	promise	as	tissue	engineering	scaffolds.28-31	Their	high	
porosity	and	pore	interconnectivity	make	them	ideal	scaffolds	for	highly	interactive,	networked	3D	
cell	cultures.32	Their	porous	nature	allows	for	deeper	and	more	uniform	nutrient	transport,	as	well	
as	allowing	cells	 to	 freely	migrate	 throughout	 the	structure	with	 limited	 resistance.	Polymerised	
high	 internal	 phase	 emulsions	 (PolyHIPEs)	 are	 a	 class	 of	 solid	 porous	 material	 that	 have	 been	
shown	to	be	effective	as	tissue	engineering	scaffolds.29,	33-44	They	are	produced	by	a	process	called	
emulsion	templating	 in	which	the	external	phase	of	an	emulsion	 is	polymerised	and	the	 internal	
phase	is	vacated	to	leave	a	highly	porous	structure.45-47	PolyHIPEs	specifically	are	produced	using	
an	emulsion	greater	than	74%	internal	phase	volume,	of	which	is	the	minimum	phase	volume	that	
ensures	complete	droplet	packing	of	uniform	droplet	size.48	This	yields	a	highly	porous	structure	of	
interconnected	 voids.	 In	 most	 cases,	 polyHIPEs	 are	 produced	 via	 thermally	 initiated	 radical	
polymerisation	reactions.	However,	these	reactions	are	relatively	slow	and	require	emulsions	that	
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are	 sufficiently	 stable	 at	 polymerisation	 temperature	 (typically	 50-70	 oC),	 ruling	 out	 the	 use	 of	
certain	monomers.	More	 recently,	 photoinitiated	 thiol-ene	 click-chemistry	 reactions	 have	 been	
used	 to	 polymerise	 emulsions	 that	 lack	 long-term	 stability.39,	 49,	 50	 This	 broadens	 the	 range	 of	
monomers	 that	 can	 potentially	 be	 used	 for	 the	 synthesis	 of	 polyHIPE	 materials,	 in	 particular	
allowing	the	use	of	monomers	that	do	not	lead	to	highly	stable	emulsions.	
	
The	work	 presented	 here	 investigates	 the	 creation	 of	 thiol-ene	 polyHIPE	materials	 with	 similar	
mechanical	properties	to	that	of	mammalian	brain	tissue.	The	methods	employed	include	reducing	
the	 crosslink	 density	 of	 the	network	polymer,	 increasing	 the	distance	between	 crosslinks	 in	 the	
network	 and	 increasing	 the	 overall	 porosity	 of	 the	 material.	 The	 mechanical	 properties	 of	 the	
materials	produced	were	determined	in	tensile	mode.	The	ability	of	materials	to	absorb	medium	
was	 determined	 as	well	 as	 degradability	 under	 biological	 and	 non-biological	 conditions.	 Finally,	
biocompatibility	of	materials	was	investigated	by	exploring	their	ability	to	support	the	adherence	
and	short	term	expansion	of	hiPSC-derived	neural	progenitor	cells.	
	
Experimental	
Materials	
Trimethylolpropane	 triacrylate	 (TMPTA),	 trimethylolpropane	 tris(3-mercaptopropionate)	
(TMPTMP),	 1,6-hexanediol	 diacrylate	 (HDDA),	 poly(ethylene	 glycol)	 diacrylate	Mn=700	 (PEGDA),	
diphenyl(2,4,6-trimethylbenzoyl)phosphine	 oxide/2-hydroxy-2-methylpropiophenone	 blend	
(photointiator),	phosphate	buffered	saline	(PBS),	1,2-dichloroethane	and	laminin	from	Engelbreth-
Holm-Swarm	 murine	 sarcoma	 basement	 membrane	 were	 all	 purchased	 from	 Sigma-Aldrich.	
AggreWellTM800	plates,	NeurocultTM	NS-A	Basal	Medium	(Human),	NeurocultTM	NS-A	Proliferation	
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Supplement,	 STEMdiffTM	 Neural	 Progenitor	 Medium	 (STEMdiff	 NPM),	 STEMdiffTM	 Neural	
Progenitor	 Freezing	Medium	 (STEMdiff	 NPM	 Freeze	Medium)	 and	 Y-27632	 RHO/ROCK	 inhibitor	
were	 obtained	 from	 STEMCELL	 Technologies.	 Essential	 8TM	 Medium,	 Geltrex	 LDEV-Free	 hESC-
Qualified	 Reduced	 Growth	 Factor	 Basement	 Membrane	 Matrix,	 EDTA	 (0.5M)	 pH	 8.0,	 TrypLETM	
Express	 Enzyme	 (1X),	 DMEM/F12	 (Ham)	 (1:1)	 +	 GlutaMAXTM-I	 (1X)	 supplement	 (DMEM/F12),	
StemPro®	Accutase®	Cell	Dissociation	Reagent,	Trypan	Blue	Stain,	Goat	anti-Rabbit	IgG	(H+L)	Alexa	
Fluor®	 568,	 4’,6-Diamidino-2-Phenylindole,	 Dihydrchloride	 (DAPI),	 NuncTM	 Lab-TekTM	 II	 8-well	
Chamber	 SlidesTM	 and	 Dulbecco’s	 phosphate	 buffered	 saline	 without	 calcium	 and	 magnesium	
(DPBS)	were	all	purchased	from	Life	Technologies	Australia	Pty	Ltd.	HYPERMERTM	B-246SF-LQ-(AP)	
was	 obtained	 from	 Croda.	 3CB2	 Anti-Vimentin	 IgM	 mouse	 antibody	 was	 purchased	 from	
Developmental	Studies	Hybridoma	Bank.	Recombinant	human	basic	FGF	(bFGF)	and	recombinant	
human	 EGF	 were	 purchased	 from	 PeproTech.	 Corning®	 Costar®	 Ultralow	 attachment	 multiwell	
plates	were	 purchased	 from	Corning.	 Recombinant	Human	Noggin	 protein	was	 purchased	 from	
R&D	Systems.	
	
PolyHIPE	Synthesis	
The	polyHIPE	synthesis	procedure	was	developed	from	the	work	of	Lovelady	et	al.49	A	hydrophobic	
phase	 mixture	 consisting	 of	 TMPTMP,	 a	 multifunctional	 acrylate	 monomer	 (TMPTA,	 HDDA	 or	
PEGDA)	(Figure	1),	surfactant	Hypermer	B246	(3%	w/w	of	hydrophobic	phase)	and	photoinitiator	
(5%	w/w	of	hydrophobic	phase)	was	dissolved	in	dichloroethane	(for	amounts	see	Table	S1).	The	
mixture	was	added	to	a	two-neck	250	ml	round	bottom	flask	and	stirred	at	a	defined	speed	(Table	
S1)	 using	 a	D-shaped	polytetrafluoroethylene	 (PTFE)	 overhead	paddle	 stirrer	 (Sigma-Aldrich).	 	 A	
hydrophilic	phase	of	MilliQ	water	was	added	to	the	mixture	drop-wise	at	approximately	1	drop	per	
second	until	all	water	was	added.	The	mixture	was	then	stirred	for	a	further	period	of	time	(Table	
S1).	The	HIPE	mixture	was	then	poured	into	a	cylindrical	PTFE	mould	between	two	glass	plates	and	
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passed	under	a	high	intensity	UV	irradiator	(Fusion	UV	Systems,	 Inc.	Light	Hammer®	6	UV	curing	
system	with	an	Heraeus	belt	conveyer)	four	times	(twice	on	each	side)	at	a	power	flux	of	5	W/cm2	
and	 belt	 speed	 of	 3.2	m/min.	 The	 resulting	 polyHIPE	 was	 washed	 in	 an	 immersion	 of	 acetone	
overnight.	The	polyHIPE	was	further	washed	by	Soxhlet	extraction	using	dichloromethane	for	24	
hours.	The	polyHIPE	was	air	dried	overnight	then	vacuum	dried	for	24	hours	at	room	temperature.	
PolyHIPE	materials	produced	by	this	method	are	known	to	contain	residual	 thiols	 resulting	 from	
acrylate	 homopolymerisation	 that	 competes	 with	 thiol-acrylate	 reactions51.	 Residual	 thiol	
concentrations	were	measured	by	Ellman’s	assay	and	were	found	to	range	from	28-63	µmol/g	(see	
Supplementary	Information).	
	
	
Figure	1.	Monomers	used	in	polyHIPE	synthesis.	Trimethylolpropane	tris(3-mercaptopropionate)	
(A),	trimethylolpropane	triacrylate	(B),	1,6-hexanediol	diacrylate	(C),	and	poly(ethylene	glycol)	
diacrylate	(n=13)	(D).		
	
Scanning	Electron	Microscopy	
PolyHIPE	 structure	 was	 analysed	 using	 an	 FEI	 Nova	 NanoSEM	 450	 FEGSEM	 operating	 at	 5	 kV.	
Samples	were	mounted	on	aluminium	stubs	using	 carbon	 tape	and	 sputter-coated	with	 iridium.	
A	 B	
C	 D	
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Void	sizes	were	measured	using	Image	J	imaging	software	by	selecting	100	random	voids	across	an	
image	 of	 200x	 magnification.	 A	 statistical	 correction	 factor	 was	 used	 to	 account	 for	
underestimations	of	void	sizes	in	the	cross-sectional	image.52	
	
Helium	Pycnometry	
Skeletal	 density	 of	 polyHIPE	 materials	 was	 analysed	 using	 a	Micrometrics	 AccuPyc	 II	 1340	 Gas	
Pycnometer.	Experiments	were	performed	using	helium	gas	at	a	pressure	of	150	kPa	and	a	 cup	
size	of	10	cm3.	10	measurements	of	each	sample	were	made.	Porosity	was	determined	using	the	
following	expression	(Equation	1):	
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 % = 1− !"#$ !"#$%&' !"#$#%&$ !"#$%&' ×100	 	 	 [1]	
Mechanical	Testing	of	Dry	Samples	
PolyHIPE	samples	were	tensile	tested	to	ASTMD638	standards.	PolyHIPE	materials	were	made	in	
sheets	approximately	3	mm	thick.	Dumbbell-shaped	samples	were	then	stamped	out	of	the	sheet	
using	an	ASTMD638	Type	V	die.	Samples	were	 tensile	 tested	using	an	 Instron	5848	MicroTester	
with	Bluehill®	software.	Samples	were	tensile	loaded	uniaxially	at	a	constant	extension	rate	of	10	
mm/min	until	break.	
	
In	situ	Mechanical	Testing		
PolyHIPE	samples	were	tensile	tested	under	mimicked	biological	conditions	in	phosphate	buffered	
saline	 at	 37°C	 using	 a	 Bose	 Electroforce	 3200	 II	 in	 situ	 biomechanical	 tester	 with	 WinTest®	 7	
software.	 Samples	 were	 placed	 in	 a	 chamber	 of	 PBS	 recirculating	 at	 37°C.	 Samples	 were	 then	
loaded	 uniaxially	 at	 a	 constant	 extension	 rate	 of	 10	 mm/min	 to	 the	 extension	 limits	 of	 the	
apparatus.	
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Analysis	of	Stress-Strain	data	
All	stress-stain	data	obtained	from	these	materials	exhibited	distinct	non-linear	 J-shaped	curves.	
The	 elastic	modulus	was	 deduced	 from	 these	 curves	 using	 a	method	 described	 by	 Kendall	 and	
Fuller.53	Briefly,	the	data	was	fit	with	the	following	power	equation	(Equation	2):	
𝜎 = 𝜀𝜖!	 	 	 	 	 	 [2]	
Where	σ	is	the	nominal	stress	(force/original	cross	sectional	area),	ϵ	is	the	nominal	strain	(change	
in	length/original	length)	and	ε	is	a	constant	corresponding	to	Young’s	modulus.	
	
Swelling	Experiments	
Samples	were	dried	in	a	vacuum	oven	until	constant	mass	was	reached	(md).	Rectangular	samples	
of	dimensions	3x5x5	mm	were	submerged	in	15	ml	PBS	and	incubated	at	37°C	for	up	to	2	hours.	At	
different	 time	 intervals	 samples	 were	 removed	 from	 solution.	 The	 wet	 weight	 (mw)	 was	
immediately	measured.	Samples	were	then	pressed	between	two	pieces	of	paper	towel	to	vacate	
any	 PBS	 in	 pores	 and	 swollen	 weight	 (msw)	 was	 then	 determined.	 Two	 calculations	 were	
performed	(Equations	3-4):	
	
𝐹𝑙𝑢𝑖𝑑 𝑢𝑝𝑡𝑎𝑘𝑒 𝑜𝑓 𝑤ℎ𝑜𝑙𝑒 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 (%) = !!!!!!! ×100	 	 	 [3]	
	
𝐹𝑙𝑢𝑖𝑑 𝑢𝑝𝑡𝑘𝑎𝑒 𝑜𝑓 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 % = !!"!!!!! ×100	 	 [4]	
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Degradation	Experiments	
Clean,	dry,	rectangular	polyHIPE	samples	of	dimensions	3x10x10	mm	and	known	weight	(mi)	were	
placed	 in	 15	 ml	 of	 PBS	 in	 TeflonTM	 capped	 vials	 at	 37°C	 on	 orbital	 rotation	 at	 70	 rpm.	 After	
different	time	intervals	up	to	77	days,	samples	were	removed	from	solution,	washed	three	times	
with	 water,	 vacuum	 dried	 to	 constant	 mass	 and	 weighed	 (mf).	 Percentage	 mass	 loss	 was	
calculated	(Equation	5).	Accelerated	degradation	experiments	were	performed	to	the	exact	same	
conditions	with	0.1	M	NaOH,	at	room	temperature,	instead	of	PBS.		
	
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑚𝑎𝑠𝑠 𝑙𝑜𝑠𝑠 % = !!!!!!! ×100	 	 	 			[5]	
	
Cell	culture		
All	work	using	hPSCs	and	derivative	NPCs	was	carried	out	in	accordance	with	Australia’s	National	
Health	and	Medical	Research	Council	(NHMRC)	National	Statement	on	Ethical	Conduct	in	Human	
Research	 (2007,	updated	2015),	 the	Australian	Code	of	Responsible	Conduct	of	Research	 (2007)	
and	with	approvals	from	Monash	University	and	the	CSIRO	Human	Research	Ethics	Offices.	
	
The	 iPS	 cell	 line	 HDF51i-509,	 previously	 derived	 by	 Sendai	 reprogramming	 of	 human	 dermal	
fibroblast	 (HDF)	cells,54	was	kindly	provided	under	materials	 transfer	agreement	by	Prof.	 Jeanne	
Loring	(The	Scripps	Research	Institute,	CA,	USA).	HDF51i-509	hiPSCs	were	maintained	in	Essential	
8™	 (E8)	 medium	 on	 Geltrex™-coated	 tissue	 culture	 polystyrene	 at	 37°C	 in	 an	 atmosphere	
containing	5%	CO2	and	passaged	using	0.5	mM	EDTA.55	
	
HiPSCs	were	directly	differentiated	in	vitro	to	neural	stem	and	progenitor	precursor	(NPC)	cultures	
in	 serum-free	 culture	 via	 the	 initial	 formation	 of	 uniform-sized	 cell	 aggregate	 embryoid	 bodies	
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(EBs),56	 with	 neural	 lineage	 induction	 by	 bone	 morphogenic	 protein	 (BMP)	 inhibition	 in	
neurosphere	 suspension	 culture	 and	 subsequent	 monolayer	 mitogen	 expansion	 of	 generated	
NPCs.14-16,	57,	58	Briefly,	hiPSCs	harvested	from	E8	maintenance	culture	with	Accutase	were	seeded	
in	 AggreWellTM800	 plates	 at	 10,000	 cells/microwell	 (STEMCELL	 Technologies,	 as	 per	
manufacturer’s	 protocol)	 in	 serum-free	 NeuroCultTM	 NS-A	 human	 Basal	 Medium	 supplemented	
with	NeuroCultTM	NS-A	human	Proliferation	Supplement,	20	ng/µl	recombinant	human	bFGF	and	
20	 ng/µl	 recombinant	 human	 EGF,	 (Complete	 NeuroCult	 NS-A	 Proliferation	 medium),	 with	 the	
addition	 of	 500	 ng/ml	 human	 noggin	 and	 10	 µM	 ROCK	 inhibitor	 Y-27632.59	 AggreWell	 cultures	
were	 incubated	 undisturbed	 for	 24-36	 hours	 at	 37°C/5%	 CO2	 before	 commencing	 partial	 daily	
media	changes	of	Complete	NeuroCult	NS-A	Proliferation	medium	supplemented	with	500	ng/ml	
noggin.	EBs	were	transferred	after	5	days	from	AggreWellTM	plates	to	ultra-low	attachment	6-well	
(10	cm2/well)	plates	for	neurosphere	induction	using	the	same	noggin-supplemented	proliferation	
medium	as	above	for	a	further	9	days,	replenishing	medium	every	2	days.	
	
Neurospheres	 were	 mechanically	 dissociated	 using	 TrypLE	 Express	 with	 15-20	 minute/37°C	
incubations	and	cells	seeded	at	5x104/cm2	onto	tissue	culture	wells	coated	with	laminin	(10	µg/ml	
in	 DMEM/F12,	 coating	 1	 µg/cm2)	 in	 Complete	 NeuroCult	 NS-A	 Proliferation	 to	 generate	 an	
adherent	monolayer	 culture	 of	 neural	 precursor	 cells.	NPCs	were	 passaged	 at	 ~80%	 confluence	
each	 4-7	 days	 using	 Accutase,	 replating	 at	 ~5-10x104	 cells/cm2	 and	 transferring	 renewing	 stem	
cells	 to	 STEMdiff	 NPM	 from	 the	 third	 passage,	 with	 media	 changes	 each	 second	 day	 (as	 per	
STEMdiff	Neural	System	protocols,	STEMCELL	Technologies).	An	established	HDF51-509i	NPC	line	
was	 successfully	maintained	 for	up	 to	15	passages	 in	 STEMdiff	NPM,	 cryopreserved	 in	 STEMdiff	
NPM	 Freeze	 Medium	 and	 thawed	 as	 an	 expanding	 population	 of	 NPCs,	 validated	 by	
immunocytochemical	 staining	 for	 Vimentin	 expression.	 HNPCs	 were	 routinely	 expanded	 on	
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laminin	coated	tissue	cultureware	 in	STEMdiff	NPM	for	up	to	10	passages	prior	to	adaptation	to	
scaffold	test	surfaces.	
	
3D	 hNPC	 culture	 on	 scaffolds:	 circular	 disk	 scaffolds	 of	 15	mm	diameter	 and	 200	 µm	 thickness	
were	 cut	 from	 a	 cylinder	 of	 polyHIPE	 by	 sectioning	 using	 a	 Leica	 VT100	 S	 vibrating-blade	
microtome.	 Samples	 too	 soft	 to	 section	 with	 a	 vibratome	were	 embedded	 in	 optimum	 cutting	
temperature	 (OCT)	 medium	 and	 sectioned	 using	 a	 Leica	 CM3050-S	 Cryostat.	 Disks	 were	 then	
assembled	 into	 well	 inserts	 purchased	 from	 ReproCELL	 Europe	 Ltd	 and	 placed	 in	 12-well	 cell	
culture	plates	(3.8	cm2/well).	Scaffolds	were	sterilised	by	submerging	4	mL/well	of	70%	v/v	ethanol	
in	water	for	10	minutes.	Scaffolds	were	then	washed	twice	with	3.5	mL/well	of	DMEM/F12	for	5	
minutes	each	wash.	Scaffolds	were	coated	in	3.5	mL/well	of	10	µg/mL	laminin	in	DMEM/F12	for	2	
hours	at	room	temperature.	The	laminin	solution	was	aspirated	and	1x106	HDF51i-509	NPCs	in	150	
μL	 of	 STEMdiff	NPM	were	 place	 on	 top	 of	 the	 scaffold.	 Scaffolds	were	 incubated	 at	 37°C	 in	 an	
atmosphere	of	5%	CO2	for	3	hours	to	allow	cells	to	settle	and	attach	to	the	material,	after	which	an	
extra	3.5	mL	of	STEMdiff	NPM	was	carefully	added	so	as	not	to	disturb	cell	attachment.	STEMdiff	
NPM	was	then	replenished	every	1-2	days.		Following	3	days	of	culture	scaffolds	were	fixed	in	10%	
neutral	buffered	formalin	pH	7	for	10-15	minutes	for	histological	analyses.	
	
Histology	and	Staining	
Fixed	 scaffolds	were	 processed	 to	 remove	water	 and	 infiltrate	with	wax.	 Samples	 underwent	 a	
four	hour	 formalin	processing	program	of	80%	ethanol,	 xylene	 then	paraffin	on	a	Leica	PELORIS	
Tissue	Processor.	Processed	scaffolds	were	then	embedded	 in	paraffin	wax	and	sectioned	 into	4	
μm	 slices	 using	 a	 Rotary	 Microtome	 CUT	 4060	 (microTEC).	 Sections	 were	 then	 mounted	 on	
polylysine	 slides	 (Thermo	 Scientific)	 and	 air-dried	 overnight	 at	 room	 temperature.	 To	 stain,	
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samples	were	dewaxed	in	xylene	and	washed	with	ethanol	and	water.	Samples	were	then	stained	
in	Harris’s	Haematoxylin	 for	5	min.	Samples	were	 then	washed	with	water,	quickly	 immersed	 in	
acid	 alcohol	 and	 again	washed	with	water	 before	 counterstaining	with	 Eosin	 for	 5	min.	 Stained	
sections	were	then	washed	with	ethanol,	dehydrated	with	xylene	and	cover	slipped.	Samples	were	
then	 imaged	 with	 an	 Olympus	 BX51	 microscope	 in	 brightfield	 mode	 using	 a	 Nuance	 FX	
Multispectral	Imaging	System.	
	
Immunocytochemistry		
For	 immunocytochemical	 staining,	 sections	 were	 prepared	 as	 described	 above.	 Sections	
underwent	 heat	 induced	 epitope	 retrieval	 at	 98°C	 for	 30	 minutes	 in	 a	 Dako	 Target	 Retrieval	
Solution,	 citrate	 pH	 6	 solution	 on	 a	Dako	 PT	 Link	 Rinse	 Station.	HNPCs	 cultured	 on	 8-well	 glass	
chamber	 slides	 were	 fixed	 using	 4%	 formaldehyde	 in	 PBS	 and	 did	 not	 undergo	 the	 epitope	
retrieval	process.	Samples	were	incubated	with	blocking	buffer,	10%	v/v	normal	goat	serum	in	PBS	
(blocking	buffer),	for	1	hour	at	room	temperature	then	incubated	in	4.4	μg/mL	3CB2	Anti-Vimentin	
IgM	mouse	primary	 antibody	 in	blocking	buffer	 for	 1	hour	 at	 room	 temperature.	 Samples	were	
then	washed	 three	 times	 in	 PBS	 for	 5	minutes	 each	with	 agitation	 then	 incubated	 in	 goat	 anti-
rabbit	 IgG	 (H+L)	Alexa	Fluor®	568	 secondary	antibody	 (4	μg/mL	 (1:500)	 in	blocking	buffer)	 for	1	
hour	at	room	temperature.	Samples	were	subsequently	washed	three	times	in	PBS	for	5	minutes	
each	with	agitation,	then	counterstained	with	DAPI	(2	μg/ml	or	1:500)	and	incubated	for	5	minutes	
at	 room	 temperature.	 Finally,	 samples	 were	 washed	 in	 PBS	 for	 5	 minutes,	 cover	 slipped	 and	
imaged	using	a	Leica	SP8	confocal	microscope	equipped	with	a	x40	water	objective	and	running	
LAS	AF	software	(Leica	MicroSystems.	Manheim,	Germany).	
	 15	
 
Results	and	Discussion	
PolyHIPE	Synthesis	and	Analysis	
The	 monomer	 trimethylolpropane	 tris(3-mercaptopropionate)	 (trithiol)	 was	 reacted	 with	 three	
different	 multifunctional	 acrylate	 crosslinkers:	 trimethylolpropane	 triacrylate	 (TMPTA),	 1,6-
hexanediol	diacrylate	(HDDA)	and	poly(ethylene	glycol)	diacrylate	(PEGDA)	to	produce	materials	of	
varying	 cross-linking	 density	 and	 mechanical	 properties.	 In	 an	 attempt	 to	 reduce	 the	 elastic	
modulus	 of	 the	 materials	 to	 that	 of	 mammalian	 brain	 tissue,	 three	 approaches	 were	 taken:	
reducing	 the	 crosslink	 density,	 increasing	 the	 physical	 length	 of	 crosslinks	 and	 increasing	 the	
porosity	of	the	material.	
	
TMPTA	 polyHIPEs	 were	 successfully	 produced	 using	 conditions	 previously	 reported	 (Figure	 2A,	
Table	S1).39	Attempts	to	use	the	same	set	of	conditions	with	the	HDDA	monomer	gave	an	unstable	
emulsion,	possibly	due	to	the	reduction	in	external	phase	viscosity.	Stirrer	speed	was	increased	to	
470	 rpm,	 to	 reduce	 internal	 phase	 droplet	 size	 and	 give	 a	 HIPE	 of	 good	 stability	 that	was	 able	
polymerise	(Figure	2B).	PolyHIPE	then	made	with	the	PEGDA	monomer	under	the	original	TMPTA	
conditions	 formed	 a	 highly	 stable,	 highly	 viscous	 HIPE.	 Whilst	 very	 stable	 this	 HIPE	 would	 not	
polymerise	under	UV	 light,	possibly	due	to	monomer	density	reducing	 light	penetration	 into	the	
HIPE,	preventing	polymerisation.	Lowering	the	monomer	concentration	in	the	organic	phase	to	0.5	
M	gave	an	unstable	emulsion.	A	monomer	concentration	of	0.79	M	 in	 the	organic	phase	gave	a	
stable	 emulsion	 that	 was	 able	 to	 polymerise	 and	 give	 a	 material	 with	 the	 expected	 polyHIPE	
morphology	(Figure	2C).	Emulsions	stirred	for	an	additional	120	minutes	after	the	addition	of	the	
droplet	phase	gave	materials	of	the	most	uniform	pore	diameter.	Under	the	same	conditions	the	
PEGDA	system	formed	a	stable,	polymerisable	emulsion	up	to	85%	aqueous	phase	volume	fraction.	
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Beyond	 this	 volume	 fraction	emulsions	would	 invert	and	 stable	water-in-oil	 emulsions	were	not	
formed.	All	systems	that	successfully	polymerised,	once	washed	and	dried,	gave	a	spongy,	white	
material	of	varying	degrees	of	elasticity.		
	
All	materials	were	 observed	 by	 SEM	 to	 have	 a	 porous	 structure	 as	 a	 result	 of	 vacated	 internal	
phase	 water	 droplets	 (Figure	 2A-D).	 An	 interconnected	 porous	 network	 is	 created	 by	 internal	
phase	droplets	coming	into	contact	with	adjacent	droplets,	and	can	be	seen	in	all	materials.	Some	
defects	 can	 be	 seen	 in	 the	 materials	 made	 with	 the	 PEGDA	 monomer	 (Figure	 2C	 and	 D),	
particularly	in	the	thin	sections	between	interconnects.	This	can	possibly	be	a	result	of	strain	put	
on	 the	 soft	 material	 via	 expansion	 and	 shrinkage	 during	 the	 washing	 and	 drying	 processes.	
However,	these	small	defects	visually	had	little	effect	on	the	bulk	structure	of	the	material.		
					 	
					 	
	
A	
D	C	
B	
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Figure	2.	SEM	images	of	polyHIPE	materials	synthesised	with	TMPTA	crosslinker	at	80%	porosity	
(A),	 HDDA	 crosslinker	 at	 80%	 porosity	 (B),	 PEGDA	 crosslinker	 at	 80%	 porosity	 (C)	 and	 PEGDA	
crosslinker	at	85%	porosity	(D).	(Scale	bar	=	100	μm)	
	
SEM	 images	 were	 analysed	 using	 Image	 J	 imaging	 software	 to	 determine	 pore	 diameter	
distributions	 (Figure	 S1)	 and	 averages	 (Table	 S2).	 	 A	 pore	 diameter	 between	 20-70	 μm	 has	
generally	 been	 shown	 to	 be	 ideal	 for	 the	 ingrowth	 and	 outgrowth	 of	 neurons	 within	 porous	
scaffolds.60	The	TMPTA	polyHIPE	material	gave	the	lowest	average	pore	diameter	(30.3	±	14.9	μm)	
and	the	narrowest	pore	size	distribution	(SD	=	14.9	μm).	Despite	the	increased	stirring	speed	the	
HDDA	polyHIPE	gave	a	slightly	larger	average	pore	diameter	(44.2	μm)	than	the	TMPTA	polyHIPE,	
most	likely	due	to	the	change	in	external	phase	properties	caused	by	the	introduction	of	the	HDDA	
monomer.	The	PEGDA	polyHIPEs	also	had	 increased	average	pore	diameters	at	 the	 same	stirrer	
speed	 compared	 to	 the	 TMPTA	 polyHIPE,	 possibly	 due	 to	 the	 increased	water	 solubility	 of	 the	
PEGDA	monomer	which	can	promote	emulsion	coarsening.	The	85%	porous	PEGDA	polyHIPE	had	a	
higher	average	pore	diameter	(63.2	±	31.5	µm)	due	to	the	increased	internal	phase	volume	of	the	
emulsion.	
	
PolyHIPEs,	particularly	the	high	porosity	PEGDA	polyHIPE,	had	a	tendency	to	collapse	 if	 the	pore	
diameter	was	 too	 small	 or	 if	 the	material	was	 dried	 too	 quickly.	 It	 was	 therefore	 important	 to	
verify	whether	the	porosity	measured	was	the	same	as	that	expected	from	the	emulsion	internal	
volume	fraction.	Helium	pycnometry	was	used	to	determine	the	skeletal	density	of	the	materials,	
which	was	then	used	to	calculate	the	actual	porosity	(Table	S2).	All	materials	that	were	observed	
via	 SEM	 to	 have	 retained	 their	 porous	 structure	 were	 found	 to	 be	 within	 4%	 of	 their	 desired	
formulated	porosity.		
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Swelling	Studies	
Once	 synthesised,	 the	 polyHIPEs,	 in	 particular	 the	 PEGDA	 materials,	 were	 observed	 to	 swell	
significantly	 in	 polar	 organic	 solvents.	 Swelling	 studies	were	 performed	 to	 quantify	 the	 swelling	
ability	of	all	scaffold	materials.	The	swelling	ability	of	the	scaffold	as	a	whole	(material	and	pores)	
and	solely	the	material	was	quantified	in	PBS	at	37°C	(Figure	3).		
	
	
Figure	 3.	 PBS	 uptake	 profiles	 of	 the	 scaffold	 material	 as	 a	 whole	 (A)	 and	 solely	 the	 scaffold	
polymer	phase	(B)	(N=3,	mean	±	standard	deviation)	
	
All	 materials	 were	 expected	 to	 take	 up	 a	 certain	 amount	 of	 PBS	 due	 to	 their	 interconnected	
porous	structure.	Both	TMPTA-	and	HDDA-based	materials	reached	an	equilibrium	PBS	uptake	of	
around	100%	of	their	weight	after	approximately	10	minutes	(Figure	3A).	The	80%	porous	PEGDA	
material	 was	 found	 to	 absorb	 more	 than	 seven	 times	 its	 own	 weight	 in	 PBS	 after	 10	 minutes	
swelling.	The	highly	absorbing	capacity	of	the	PEGDA	crosslinked	materials	is	most	likely	due	to	the	
ethylene	 glycol	 backbone	 of	 the	 PEGDA	 crosslinker.	 These	 backbone	 units	 are	 able	 to	 interact	
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strongly	with	water	through	hydrogen	bonding.	Comparatively,	the	alkane	backbone	of	the	TMPTA	
and	HDDA	crosslinkers	 is	quite	hydrophobic,	hence	these	materials	take	up	less	PBS.	The	PEGDA	
material	itself	(not	accounting	for	pores)	was	also	shown	to	be	able	to	absorb	around	60%	its	own	
weight	in	PBS,	whilst	the	HDDA-	and	TMPTA-based	materials	only	were	shown	to	absorb	around	5%	
of	their	weight.	Again	this	follows	the	hypothesis	that	the	more	hydrophilic	the	backbone	of	the	
crosslinker	the	greater	its	ability	to	absorb	PBS.	
	
These	 results	 indicate	 that	 the	 PEGDA-crosslinked	 polyHIPEs	 display	 hydrogel-like	 properties	 in	
terms	 of	 their	 ability	 to	 absorb	 water.	 The	 PEGDA	 polyHIPE	 displays	 the	 characteristic	 of	 a	
hierarchical	 porosity,	 with	 pores	 due	 to	 the	 emulsion	 templating	 process	 and	 smaller	 pores	
present	 in	 the	 solid	material	 itself	which	 are	 able	 to	 absorb	water.	 An	 ability	 to	 absorb	 a	 large	
amount	of	water	translates	into	a	better	material	environment	for	cell	culture.		Materials	that	can	
absorb	 more	 medium	 allow	 for	 cells	 to	 exist	 in	 a	 more	 nutrient-rich	 environment	 inside	 the	
scaffold.	This	could	have	an	effect	on	the	growth	characteristics	of	cells	inside	the	material.	
	
Optical	Properties	
One	of	the	major	drawbacks	of	porous	materials	used	as	tissue	engineering	scaffolds	is	their	poor	
optical	properties.	The	opacity	of	solid	porous	polymers	makes	it	very	difficult	to	visualise	live	cells	
during	culture	using	conventional	microscopic	techniques.	PEGDA	polyHIPEs,	which	were	shown	to	
have	hydrogel-like	properties	due	 to	 the	presence	of	a	hydrophilic	crosslinker,	have	significantly	
enhanced	light	transmission	properties.	Due	to	the	high	water	content	of	these	materials	they	are	
far	more	 transparent	 than	both	 the	TMPTA-	and	HDDA-crosslinked	materials.	As	 can	be	 seen	 in	
Figure	4A	the	PEGDA	polyHIPEs	are	visibly	more	transparent	than	those	for	TMPTA.	Further,	under	
a	 bright	 field	 microscope	 (Figure	 4Bi-ii)	 far	 better	 resolution	 is	 observed	 due	 to	 the	 increased	
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amount	of	light	that	is	able	to	pass	through	the	material.	This	increases	the	likelihood	of	live	cell	
visualisation	during	cell	culture	using	conventional	microscopic	techniques.	
	
		
Figure	4.	TMPTA	(left)	and	PEGDA	(right)	polyHIPE	materials	swollen	in	water	and	placed	on	a	glass	
microscope	slide.	Black	cross	on	the	back	of	the	slide	to	demonstrate	transparency	(A).	Bright	field	
microscope	 images	 taken	 at	 x20	 magnification	 and	 identical	 exposure	 times	 of	 PEGDA	 (i)	 and	
TMPTA	(ii)	polyHIPE	materials	swollen	in	water	(B)	(Scale	bars	=	100	μm).	
	
Mechanical	Testing	
Tensile	testing	to	ASTMD638	standards	was	used	to	determine	mechanical	properties	of	polyHIPE	
materials.	 PolyHIPE	 samples	 were	 produced	 as	 sheets	 of	 approximately	 3	 mm	 thickness,	 from	
which	 dog	 bone-shaped	 samples	 were	 stamped	 out	 using	 an	 ASTMD638	 Type	 V	 die.	 	 All	 four	
materials	 were	 first	 tested	 in	 a	 completely	 dry	 state.	 Samples	 were	 extended	 uniaxially	 at	 a	
constant	 rate	 of	 10	mm/min	 until	 break.	 All	 samples	 exhibited	 non-linear	 j-shaped	 stress-strain	
curves,	typical	of	polymeric	foams61	and	other	biomaterials.62	Strain	at	break,	stress	at	break	and	
A	 B.i	
B.ii	
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elastic	modulus	were	obtained	from	the	plots	of	stress	vs.	strain	(Table	1).	The	TMPTA	materials	
gave	the	highest	elastic	modulus	at	68	kPa,	a	slightly	 lower	value	than	previously	 reported.39	As	
hypothesised,	 substituting	 the	 trifunctional	 crosslinker	 for	 a	 difunctional	 crosslinker	 produced	 a	
significant	 reduction	 in	 the	elastic	modulus	 from	68	 to	27	kPa.	 Interestingly,	 the	 strain	at	break	
increased,	most	likely	due	to	added	flexibility	in	the	polymer	network	caused	by	the	reduction	in	
the	degree	of	crosslinking.	The	introduction	of	a	longer,	PEG-based,	difunctional	crosslinker	gave	
no	significant	reduction	in	elastic	modulus	at	the	same	porosity	value,	but	did	however	produce	a	
large	increase	in	both	stress	and	stain	at	break	compared	to	the	HDDA-crosslinked	material.	Again,	
this	is	most	likely	due	to	the	added	flexibility	in	the	polymer	network,	this	time	brought	about	by	a	
longer	difunctional	crosslinker	which	increases	the	chain	length	between	crosslinks.	Increasing	the	
porosity	of	 the	PEGDA	polyHIPE	 from	80	 to	85%	produced	no	significant	change	 in	 the	strain	at	
break,	but	did	however	give	a	drop	in	the	stress	at	break	to	99	kPa	and,	more	importantly,	a	drop	
in	the	elastic	modulus	to	13	kPa.	As	previously	mentioned,	the	elastic	modulus	of	the	mammalian	
brain	 has	 been	 reported	 as	 being	 in	 the	 range	of	 0.1	 –	 24	 kPa;	 the	 elastic	modulus	 of	 the	 85%	
porous	PEGDA	polyHIPE	in	the	dry	state	lies	in	this	range.			
	
Table	1.	Mechanical	properties	of	polyHIPE	materials	in	their	dry	statea	
	 Strain	at	Break	(%)	 Stress	 at	 Break	
(kPa)	
Elastic	 Modulus	
(kPa)	
TMPTA_80%	 250±8.6	 220±15	 68±1.7	
HDDA_80%	 290±66	 100±28	 27±3.2	
PEGDA_80%	 730±60	 220±21	 24±1.1	
PEGDA_85%	 620±52	 99±12	 13±0.6	
a	N=6,	mean±standard	deviation	
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Due	to	the	extensive	swelling	of	the	PEGDA-based	polyHIPEs,	tensile	testing	was	also	performed	in	
PBS	at	37°C	to	mimic	 in	vivo	conditions.	Due	to	the	extension	 limitations	of	the	apparatus,	 tests	
could	 not	 be	 performed	 to	 break.	 Only	 elastic	 modulus	 values	 were	 obtained	 from	 the	 stress-
strain	 data.	 Samples	 again	were	produced	 as	 sheets	 of	 approximately	 3	mm	 thick.	 Sheets	were	
immersed	in	PBS	for	24	hours	to	reach	equilibrium	swelling.	Dog	bone	samples	were	then	stamped	
out	of	the	swollen	sheet	using	an	ASTMD638	Type	V	die.		
	
	
Figure	 5.	 	 Comparison	 of	 elastic	modulus	 of	 PEGDA	 based	 polyHIPEs	 under	 dry	 conditions	 and	
mimicked	biological	conditions	swollen	(S)	in	PBS	at	37°C	(N=6,	mean	±	standard	deviation)	
	
A	 significant	 reduction	 in	modulus	was	 observed	 for	 both	 80	 and	 85%	 porous	 PEGDA	 polyHIPE	
materials	when	tested	swollen	under	mimicked	biological	conditions	(Figure	5).		When	swollen,	a	
given	volume	of	PEGDA	polyHIPE	contains	less	polymeric	material	then	the	same	given	volume	in	
the	 dry	 state.	 This	 reduction	 in	material	 is	 most	 likely	 the	 reason	 as	 to	 why	 the	modulus	 was	
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shown	to	decrease	 in	 the	swollen	state.	Both	80	and	85%	PEGDA	materials	 in	 the	swollen	state	
display	elastic	modulus	values	 in	 the	 range	 reported	 for	 that	of	mammalian	brain	 tissue	at	18.4	
and	 8.6	 kPa	 respectively.	 These	 two	 materials	 display	 ideal	 mechanical	 properties	 for	 use	 as	
scaffolds	for	mammalian	neural	tissue	engineering.		
	
Degradation	Studies	
A	tissue	engineering	scaffold’s	ability	to	degrade	in	a	timely	manner	and	allow	normal	tissue	ECM	
synthesis	 to	 take	 over	 can	 greatly	 enhance	 its	 ability	 to	 produce	 tissue	 that	 more	 accurately	
represents	that	found	in	vivo.	It	was	hypothesised	that	these	thiol-ene	materials	could	degrade	via	
ester	 hydrolysis.	Materials	were	 placed	 in	 PBS	 at	 37°C	 and	 their	 change	 in	mass	 over	 time	was	
determined	 (Figure	 6A).	 Materials	 were	 also	 placed	 in	 0.1	 M	 NaOH	 at	 room	 temperature	 to	
accelerate	the	ester	hydrolysis	degradation	process	(Figure	6B).	
	
The	80%	porous	PEGDA	crosslinked	material	was	shown	to	degrade	at	the	fastest	rate	under	both	
mimicked	biological	and	accelerated	conditions.	This	is	most	likely	due	to	the	high	affinity	to	water	
of	the	material,	attracting	water	and	increasing	its	access	to	the	ester	groups.	The	HDDA	material	
degraded	slower	than	the	PEDGA	material,	but	faster	than	the	TMPTA	material	under	accelerated	
conditions.	Despite	having	 the	same	concentration	of	ester	 linkages	as	 the	TMPTA	material,	 the	
HDDA	material	 in	theory	has	a	lower	cross-link	density	giving	it	 less	impeded	access	for	water	to	
attack	the	ester	groups.	The	TMPTA	material	displayed	a	significantly	slower	degradation	rate	than	
both	 the	 HDDA	 and	 PEGDA	materials	 under	 accelerated	 conditions.	 The	 TMPTA	material	 is	 the	
least	 liable	 to	 hydrolytic	 degradation	 as	 it	 has	 a	 hydrophobic	 crosslinker	 and	 in	 theory	 has	 the	
highest	cross-link	density	of	the	materials.	
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Figure	 6.	 Materials	 degradation	 experiments.	 Degradation	 under	 mimicked	 physiological	
conditions	 in	 PBS	 at	 37°C	 (A)	 and	 under	 accelerated	 conditions	 in	 0.1M	 NaOH	 at	 room	
temperature	(B).	(N=3,	mean	±	standard	deviation)	
	
Under	mimicked	biological	 conditions	 all	materials	 exhibited	 slow	degradation	profiles.	After	 77	
days	 immersion	 in	PBS	at	37°C,	PEGDA_80%,	HDDA	and	TMPTA	materials	exhibited	only	2.1,	1.7	
and	3.8%	mass	 loss.	The	PEGDA_80%	material	showed	the	greatest	degradation	rate.	There	was	
no	significant	difference	between	the	degradation	rate	of	 the	HDDA	and	TMPTA	materials.	 	The	
PEGDA_80%	material	displayed	rapid	degradation	 in	the	0.1	M	NaOH	solution.	The	material	was	
seen	 to	 be	 fully	 solubilised	 within	 30	 minutes	 of	 immersion	 in	 the	 basic	 solution.	 The	 HDDA	
material	was	the	next	fastest	to	fully	degrade,	and	was	shown	to	completely	degrade	after	40	days	
under	accelerated	conditions.	After	74	days	under	accelerated	conditions	the	TMPTA	was	slowest	
to	degrade	with	a	percentage	mass	loss	of	52%.	
	
3D	Human	Neural	Progenitor	Cell	Culture	
Human	HDF51i509	 iPSC-derived	NPCs	were	transferred	from	validated	expansion	cultures	on	2D	
laminin-coated	tissue	culture	polystyrene	(TCPS)	(Figure	7A-B)	to	test	cultures	on	all	four	scaffold	
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materials	 (TMPTA,	 HDDA,	 PEGDA_80%,	 PEGDA_85%)	 as	 well	 as	 on	 Alvetex®,	 a	 control	 scaffold	
purchased	from	ReproCELL,	all	coated	in	10	μg/mL	laminin.	Scaffolds	were	each	seeded	with	1x106	
hNPCs	(per	scaffold	disk)	and	cultured	for	3	days.		
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Figure	7.	HDF51i509	hNPCs	(passage	18)	seeded	at	1x106	cells/scaffold	and	cultured	for	3	days	on	
laminin-coated	 scaffold	 materials	 TMPTA	 (A),	 HDDA	 (B),	 PEGDA_85%	 (C),	 PEGDA_80%	 (D)	 and	
Alvetex®	control	(E)	stained	with	hematoxylin	and	eosin.	(Scale	bar	=	200	μm)	
	
By	 H&E	 staining,	 NPCs	 were	 observed	 to	 be	 distributed	 throughout	 each	 of	 the	 five	 materials	
(Figure	7A-E).	All	sections	of	polyHIPE	materials	displayed	cell	densities	comparable	to	that	for	the	
commercially	 available	 Alvetex®	 scaffold,	which	 has	 demonstrated	 biocompatibility	with	 a	wide	
range	of	cell	types.	HNPCs	appear	to	be	distributed	throughout	all	materials,	and	do	not	appear	to	
be	residing	on	the	top	and	bottom	surfaces	of	any	materials.	The	hematoxylin	(dark	purple)	seems	
to	stain	strongly	the	hydrophilic	PEGDA	materials,	making	it	slightly	more	difficult	to	visualise	the	
hNPCs	(Figure	7C	and	D).	Interestingly,	the	eosin	counterstain	(light	purple)	seems	to	have	stained	
the	TMPTA	scaffold	material.	These	results	 indicate	potential	 for	these	materials	as	scaffolds	for	
longer	term	3D	human	neural	progenitor	cell	culture	studies.	
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Figure	8.	HDF51i509	hNPCs	(passage	18)	seeded	at	1x106	cells/scaffold	and	cultured	for	3	days	on	
laminin-coated	scaffolds,	PFA-fixed	and	immunostained	with	3CB2	anti-vimentin,	detected	by	Alex	
Fluor	568	(red).	Cell	nuclei	are	counterstained	with	DAPI	(blue).	TMPTA	(A),	HDDA	(B),	PEGDA_80%	
(C),	PEGDA_85%	(D)	and	Alvetex	control	(E).	Mouse	IgM	isotype	and	goat	anti-mouse	IgM	AF568	
controls	in	Supplementary	Information.	
	
To	demonstrate	a	phenotypic	 identity	 for	 the	 iPSC-derived	hNPCs	cultured	within	 these	scaffold	
materials,	cells	were	immunostained	to	detect	the	expression	of	vimentin,	a	type	III	intermediate	
filament	protein63	that	contributes	to	the	filamentous	network	of	the	cell	cytoskeleton.64	Vimentin	
is	 found	 in	 the	 radial	 glial	 cells	 that	 arise	 from	 the	 primitive	 neuroepithelial	 lineage	 of	 the	
developing	CNS	and	give	 rise	both	 in	vivo	and	 in	vitro	 from	the	early	differentiation	of	hPSCs	 to	
neurons,	 astrocytes	 and	 oligodendrocytes.65,	 66	 HNPCs	 cultured	 on	 all	 materials	 were	 shown	 to	
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stain	positive	for	the	detection	of	vimentin	protein	(Figure	8A-E),	indicative	of	retaining	their	radial	
glial-like	state	and	multipotent	phenotype	after	transfer	from	2D	expansion	culture	to	short	term	
3D	scaffold	 cultures.	Background	blue	 staining	arises	 from	scaffold	autofluorescence	 in	 the	blue	
channel	(Figure	S3).	All	scaffold	materials	display	potential	for	longer	term	cultures	to	support	the	
growth	and	differentiation	of	hNPCs	 to	neuronal	 and	glial	 cell	 types	which	 could	have	potential	
applications	for	in	vitro	disease	modelling.	
	
Conclusions	
The	work	presented	here	describes	the	synthesis	of	a	novel	porous	polymeric	material	tailor-made	
for	 neural	 tissue	 engineering.	 The	 material,	 synthesised	 with	 a	 poly(ethylene	 glycol)	 diacrylate	
crosslinker,	has	an	elastic	modulus	of	9	kPa,	similar	to	values	reported	for	that	of	mammalian	brain	
tissue.	The	material	is	also	shown	to	absorb	up	to	7	times	more	cell	culture	medium	than	previous	
emulsion-templated	tissue	engineering	scaffolds.	PEGDA_80%	materials	were	also	shown	to	have	
significantly	 improved	 light	transmission	abilities,	beneficial	 for	cell	culture	 imaging.	PEGDA_80%	
materials	 showed	3.8%	degradation	after	11	week	 incubation	 in	mimicked	biological	 conditions.	
The	 same	material	 also	 displayed	 full	 degradation	 under	 accelerated	 conditions	 in	 0.1	M	NaOH	
after	 30	 minutes.	 After	 3	 days	 culture	 with	 iPSC-derived	 human	 neural	 progenitor	 cells,	 all	
materials	presented	 in	 this	work	displayed	the	presence	of	hNPCs	that	appear	 to	have	migrated	
throughout	 the	 scaffold.	 	 HNPCs	 within	 the	 scaffold	 materials	 were	 also	 shown	 to	 retain	
expression	 of	 the	 protein	 vimentin,	 indicative	 of	 the	materials	 supporting	 the	 viable	 culture	 of	
human	 cells	 with	 a	 radial	 glial-like	 phenotype.	 Both	 80	 and	 85%	 porous	 PEGDA	 crosslinked	
materials	show	great	promise	as	neural	tissue	engineering	scaffolds	due	to	the	combination	of	a	
favourable	environment	for	hNPC	culture	and	elastic	modulus	values	close	to	that	of	mammalian	
brain	tissue.	
	 29	
	
Conflicts	of	Interest	
There	are	no	conflicts	to	declare.	
	
Acknowledgements	
The	 authors	 acknowledge	 the	 use	 of	 facilities	 and	 technical	 assistance	 of	 Monash	 Histology	
Platform,	 Department	 of	 Anatomy	 and	 Developmental	 Biology;	 and	 of	Monash	Micro	 Imaging,	
Monash	 University,	 Victoria,	 Australia.	 HPSC-NPC	 derivation	 research	 (IG,	 JP,	 ALL,	 CO’B)	 was	
supported	by	California	Institute	for	Regenerative	Medicine	(CIRM)	joint	grant	funding	(TR3-05603)	
with	Australia’s	NHMRC	(to	CO’B,	ALL).		
	
References	
1.	 W.	K.	Raja,	A.	E.	Mungenast,	Y.	T.	Lin,	T.	Ko,	F.	Abdurrob,	J.	Seo	and	L.	H.	Tsai,	PloS	One,	
2016,	11,	e0161969.	
2.	 E.	Carletti,	A.	Motta	and	C.	Migliaresi,	in	3D	Cell	Culture:	Methods	and	Protocols,	ed.	J.	W.	
Haycock,	Humana	Press,	Totowa,	NJ,	p.	17.	
3.	 C.	D'Avanzo,	J.	Aronson,	Y.	H.	Kim,	S.	H.	Choi,	R.	E.	Tanzi	and	D.	Y.	Kim,	Bioessays,	2015,	37,	
1139-1148.	
4.	 B.	De	Strooper,	Cell,	2014,	159,	721-726.	
5.	 B.	P.	Chan	and	K.	W.	Leong,	Eur.	Spine	J.,	2008,	17	Suppl	4,	467-479.	
6.	 F.	J.	O'Brien,	Mater.	Today,	2011,	14,	88-95.	
7.	 D.	L.	Jones	and	A.	J.	Wagers,	Nat.	Rev.	Mol.	Cell	Biol.,	2008,	9,	11-21.	
8.	 P.	A.	Riquelme,	E.	Drapeau	and	F.	Doetsch,	Philos.	T.	Roy.	Soc.	B,	2008,	363,	123-137.	
	 30	
9.	 E.	Ruoslati,	Glycobiology,	1996,	6,	489-492.	
10.	 L.	W.	Lau,	R.	Cua,	M.	B.	Keough,	S.	Haylock-Jacobs	and	V.	W.	Yong,	Nat.	Rev.	Neurosci.,	
2013,	14,	722-729.	
11.	 M.	P.	Lutolf	and	H.	M.	Blau,	Adv.	Mater.,	2009,	21,	3255-3268.	
12.	 J.	A.	Thomson,	J.	Itskovitz-Eldor,	S.	S.	Shapiro,	M.	A.	Waknitz,	J.	J.	Swiergiel,	V.	S.	Marshall	
and	J.	M.	Jones,	Science,	1998,	282,	1145-1147.	
13.	 K.	Takahashi,	K.	Tanabe,	M.	Ohnuki,	M.	Narita,	T.	Ichisaka,	K.	Tomoda	and	S.	Yamanaka,	Cell,	
2007,	131,	861-872.	
14.	 L.	Gerrard,	L.	Rodgers	and	W.	Cui,	Stem	Cells,	2005,	23,	1234-1241.	
15.	 P.	Itsykson,	N.	Ilouz,	T.	Turetsky,	R.	S.	Goldstein,	M.	F.	Pera,	I.	Fishbein,	M.	Segal	and	B.	E.	
Reubinoff,	Mol.	Cell.	Neurosci.,	2005,	30,	24-36.	
16.	 M.	F.	Pera,	J.	Andrade,	S.	Houssami,	B.	Reubinoff,	A.	Trounson,	E.	G.	Stanley,	D.	Ward-van	
Oostwaard	and	C.	Mummery,	J.	Cell	Sci.,	2004,	117,	1269-1280.	
17.	 S.	M.	Chambers,	C.	A.	Fasano,	E.	P.	Papapetrou,	M.	Tomishima,	M.	Sadelain	and	L.	Studer,	
Nat.	Biotechnol.,	2009,	27,	275-280.	
18.	 A.	Tamura,	S.	Hayashi,	I.	Watanabe,	K.	Nagayama	and	T.	Matsumoto,	J.	Biomech.	Sci.	Eng.,	
2007,	2,	115-126.	
19.	 G.	T.	Fallenstein,	V.	D.	Hulce	and	J.	W.	Melvin,	J.	Biomech.,	1969,	2,	217-226.	
20.	 B.	S.	Elkin,	E.	U.	Azeloglu,	K.	D.	Costa	and	B.	Morrison,	3rd,	J.	Neurotrauma,	2007,	24,	812-
822.	
21.	 A.	Gefen,	N.	Gefen,	Q.	Zhu,	R.	Raghupathi	and	S.	S.	Margulies,	J.	Neurotrauma,	2003,	20,	
1163-1177.	
22.	 E.	R.	Aurand,	J.	Wagner,	C.	Lanning	and	K.	B.	Bjugstad,	J.	Funct.	Biomater.,	2012,	3,	839-863.	
23.	 W.	J.	Tyler,	Nat.	Rev.	Neurosci.,	2012,	13,	867-878.	
24.	 S.	Ali,	I.	B.	Wall,	C.	Mason,	A.	E.	Pelling	and	F.	S.	Veraitch,	Acta	Biomater.,	2015,	25,	253-267.	
	 31	
25.	 A.	Banerjee,	M.	Arha,	S.	Choudhary,	R.	S.	Ashton,	S.	R.	Bhatia,	D.	V.	Schaffer	and	R.	S.	Kane,	
Biomaterials,	2009,	30,	4695-4699.	
26.	 N.	D.	Leipzig	and	M.	S.	Shoichet,	Biomaterials,	2009,	30,	6867-6878.	
27.	 K.	Saha,	A.	J.	Keung,	E.	F.	Irwin,	Y.	Li,	L.	Little,	D.	V.	Schaffer	and	K.	E.	Healy,	Biophys.	J.,	2008,	
95,	4426-4438.	
28.	 T.	Garg	and	A.	K.	Goyal,	Expert	Opin.	Drug	Deliv.,	2014,	11,	767-789.	
29.	 M.	W.	Hayman,	K.	H.	Smith,	N.	R.	Cameron	and	S.	A.	Przyborski,	J.	Biochem.	Biophys.	
Methods,	2005,	62,	231-240.	
30.	 E.	Rossi,	I.	Gerges,	A.	Tocchio,	M.	Tamplenizza,	P.	Aprile,	C.	Recordati,	F.	Martello,	I.	Martin,	
P.	Milani	and	C.	Lenardi,	Biomaterials,	2016,	104,	65-77.	
31.	 K.	Seunarine,	N.	Gadegaard,	M.	Tormen,	D.	O.	Meredith,	M.	O.	Riehle	and	C.	D.	W.	
Wilkinson,	Nanomedicine,	2006,	1,	281-296.	
32.	 B.	Dhandayuthapani,	Y.	Yoshida,	T.	Maekawa	and	D.	S.	Kumar,	Int.	J.	Polym.	Sci.,	2011,	2011,	
1-19.	
33.	 W.	Busby,	N.	R.	Cameron	and	C.	A.	Jahoda,	Biomacromolecules,	2001,	2,	154-164.	
34.	 W.	Busby,	N.	R.	Cameron	and	A.	B.	C.	Jahoda,	Polym.	Int.,	2002,	51,	871-881.	
35.	 M.	Bokhari,	M.	Birch	and	G.	Akay,	Adv.	Exper.	Med.	Biol.,	2003,	534,	247-254.	
36.	 A.	Barbetta,	M.	Dentini,	E.	M.	Zannoni	and	M.	E.	De	Stefano,	Langmuir,	2005,	21,	12333-
12341.	
37.	 E.	M.	Christenson,	W.	Soofi,	J.	L.	Holm,	N.	R.	Cameron	and	A.	G.	Mikos,	Biomacromolecules,	
2007,	8,	3806-3814.	
38.	 R.	S.	Moglia,	J.	L.	Holm,	N.	A.	Sears,	C.	J.	Wilson,	D.	M.	Harrison	and	E.	Cosgriff-Hernandez,	
Biomacromolecules,	2011,	12,	3621-3628.	
39.	 S.	Caldwell,	D.	W.	Johnson,	M.	P.	Didsbury,	B.	A.	Murray,	J.	J.	Wu,	S.	A.	Przyborski	and	N.	R.	
Cameron,	Soft	Matter,	2012,	8,	10344.	
	 32	
40.	 J.	L.	Robinson,	R.	S.	Moglia,	M.	C.	Stuebben,	M.	A.	P.	McEnery	and	E.	Cosgriff-Hernandez,	
Tissue	Eng.	Part	A,	2014,	20,	1103-1112.	
41.	 J.	Naranda,	M.	Susec,	U.	Maver,	L.	Gradisnik,	M.	Gorenjak,	A.	Vukasovic,	A.	Ivkovic,	M.	S.	
Rupnik,	M.	Vogrin	and	P.	Krajnc,	Sci.	Rep.,	2016,	6,	28695.	
42.	 R.	Owen,	C.	Sherborne,	T.	Paterson,	N.	H.	Green,	G.	C.	Reilly	and	F.	Claeyssens,	J.	Mech.	
Behav.	Biomed.	Mater.,	2016,	54,	159-172.	
43.	 J.	L.	Robinson,	M.	A.	McEnery,	H.	Pearce,	M.	E.	Whitely,	D.	J.	Munoz-Pinto,	M.	S.	Hahn,	H.	Li,	
N.	A.	Sears	and	E.	Cosgriff-Hernandez,	Tissue	Eng.	Part	A,	2016,	22,	403-414.	
44.	 A.-J.	Wang,	T.	Paterson,	R.	Owen,	C.	Sherborne,	J.	Dugan,	J.-M.	Li	and	F.	Claeyssens,	Mater.	
Sci.	Eng.	C-Mater.	Biol.	Appl.,	2016,	67,	51-58.	
45.	 S.	D.	Kimmins	and	N.	R.	Cameron,	Adv.	Funct.	Mater.,	2011,	21,	211-225.	
46.	 I.	Pulko	and	P.	Krajnc,	Macromol.	Rapid	Commun.,	2012,	33,	1731-1746.	
47.	 M.	S.	Silverstein,	Polymer,	2014,	55,	304-320.	
48.	 P.	Becher,	J.	Disper.	Sci.	Technol.,	1985,	6,	147.	
49.	 E.	Lovelady,	S.	D.	Kimmins,	J.	Wu	and	N.	R.	Cameron,	Polym.	Chem.,	2011,	2,	559-562.	
50.	 M.	Turnsek	and	P.	Krajnc,	Macromol.	Chem.	Phys.,	2013,	214,	2528-2533.	
51.	 C.	R.	Langford,	D.	W.	Johnson	and	N.	R.	Cameron,	Polym.	Chem.,	2014,	5,	6200-6206.	
52.	 A.	Barbetta	and	N.	R.	Cameron,	Macromolecules,	2004,	37,	3188-3201.	
53.	 K.	Kendall	and	K.	N.	G.	Fuller,	J.	Phys.	D:	Appl.	Phys,	1987,	20,	1596-1600.	
54.	 J.	C.	Jones,	K.	Sabatini,	X.	Liao,	H.	T.	Tran,	C.	L.	Lynch,	R.	E.	Morey,	V.	Glenn-Pratola,	F.	S.	
Boscolo,	Q.	Yang,	M.	M.	Parast,	Y.	Liu,	S.	E.	Peterson,	L.	C.	Laurent,	J.	F.	Loring	and	Y.	C.	
Wang,	J.	Invest.	Dermatol.,	2013,	133,	2104-2108.	
55.	 J.	Beers,	D.	R.	Gulbranson,	N.	George,	L.	I.	Siniscalchi,	J.	Jones,	J.	A.	Thomson	and	G.	Chen,	
Nat.	Protoc.,	2012,	7,	2029-2040.	
	 33	
56.	 J.	Itskovitz-Eldor,	M.	Schuldiner,	D.	Karsenti,	A.	Eden,	O.	Yanuka,	M.	Amit,	H.	Soreq	and	N.	
Benvenisty,	Mol.	Med.,	2000,	6,	88-95.	
57.	 L.	Conti,	S.	M.	Pollard,	T.	Gorba,	E.	Reitano,	M.	Toselli,	G.	Biella,	Y.	Sun,	S.	Sanzone,	Q.	L.	
Ying,	E.	Cattaneo	and	A.	Smith,	PLoS	Biol.,	2005,	3,	e283.	
58.	 K.	C.	Sonntag,	J.	Pruszak,	T.	Yoshizaki,	J.	van	Arensbergen,	R.	Sanchez-Pernaute	and	O.	
Isacson,	Stem	Cells,	2007,	25,	411-418.	
59.	 K.	Watanabe,	M.	Ueno,	D.	Kamiya,	A.	Nishiyama,	M.	Matsumura,	T.	Wataya,	J.	B.	Takahashi,	
S.	Nishikawa,	S.	Nishikawa,	K.	Muguruma	and	Y.	Sasai,	Nat.	Biotechnol.,	2007,	25,	681-686.	
60.	 I.	Bruzauskaite,	D.	Bironaite,	E.	Bagdonas	and	E.	Bernotiene,	Cytotechnology,	2016,	68,	355-
369.	
61.	 N.	J.	Mills,	Polymer	Foams	Handbook:	Engineering	and	Biomechanics	Applications	and	
Design	Guide,	Butterworth-Heinemann,	Oxford,	2007.	
62.	 G.	A.	Holzapfel,	in	The	Handbook	of	Materials	Behavior	Models,	ed.	J.	Lemaitre,	Academic	
Press,	San	Diego,	CA,	2001,	vol.	3,	pp.	1057-1071.	
63.	 E.	Fuchs	and	K.	Weber,	Annu.	Rev.	Biochem.,	1994,	63,	345-382.	
64.	 M.	J.	Perez-Alvarez,	C.	Isiegas,	C.	Santano,	J.	J.	Salazar,	A.	I.	Ramirez,	A.	Trivino,	J.	M.	
Ramirez,	J.	P.	Albar,	E.	J.	de	la	Rosa	and	C.	Prada,	J.	Neurosci.	Res.,	2008,	86,	1871-1883.	
65.	 M.	Gotz	and	Y.	A.	Barde,	Neuron,	2005,	46,	369-372.	
66.	 M.	Sild	and	E.	S.	Ruthazer,	Neuroscientist,	2011,	17,	288-302.	
	
